P/E ratio for Ono Pharmaceutical (4528.T)
P/E ratio as of June 2023 (TTM): 11.3
According to Ono Pharmaceutical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 11.3004. At the end of 2022 the company had a P/E ratio of 19.3.
P/E ratio history for Ono Pharmaceutical from 2009 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 19.3 | -0.23% |
| 2021 | 19.3 | -9.78% |
| 2020 | 21.4 | -1.73% |
| 2019 | 21.8 | -35.89% |
| 2018 | 34.0 | 54.22% |
| 2017 | 22.0 | -95.76% |
| 2016 | 519 | -7.09% |
| 2015 | 559 | 1125.96% |
| 2014 | 45.6 | 88.9% |
| 2013 | 24.1 | 20.02% |
| 2012 | 20.1 | 10.73% |
| 2011 | 18.2 | 13.54% |
| 2010 | 16.0 | -20.01% |
| 2009 | 20.0 | 28.06% |
| 2008 | 15.6 | -27.73% |
| 2007 | 21.6 | 17.92% |
| 2006 | 18.3 | 11.06% |
| 2005 | 16.5 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.